Foot-and-mouth disease marker vaccine: Cattle protection with a partial VP1 G-H loop deleted virus antigen

Vaccine

Volumn 29, Issue 46, 2011, Pages 8405-8411

  Fowler, V L ^a   Bashiruddin, J B ^a   Maree, F F ^b   Mutowembwa, P ^b   Bankowski, B ^a   Gibson, D ^a   Cox, S ^a   Knowles, N ^a   Barnett, P V ^a  

^a INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

^b ONDERSTEPOORT VETERINARY INSTITUTE   (South Africa)

Author keywords

Foot and mouth disease; Marker vaccine; VP1 g h loop

Indexed keywords

FOOT AND MOUTH DISEASE VACCINE; MARKER VACCINE; NEUTRALIZING ANTIBODY; PROTEIN VP1; VIRUS ANTIBODY; VIRUS ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; CATTLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL INFECTION; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; INFECTION PREVENTION; NONHUMAN; PRIORITY JOURNAL; VIRUS PARTICLE;

ANIMALS; ANTIBODIES, VIRAL; CATTLE; CATTLE DISEASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; VACCINES, MARKER; VIRAL VACCINES;

EID: 80054001149     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.08.035     Document Type: Article

References (23)

1. Thompson D., Muriel P., Russell D., Osborne P., Bromley A., Rowland M., Creigh-Tyte S., Brown C. Economic costs of the foot and mouth disease outbreak in the United Kingdom in 2001. Rev Sci Tech Off Int Epiz 2002, 21:675-687.
2. Anonymous. National Audit Office. The 2001 outbreak of foot-and-mouth disease HC 939 Session 2001-2001. London: Stationary Office.
3. Bachrach H.L. Foot-and-mouth disease. Ann Rev Microbiol 1968, 22:210-244.
4. Doel T.R., Vaccines F.M.D. Virus Res 2003, 91:81-99.
5. Clavijo A., Wright P., Kitching P. Developments in diagnostic techniques for differentiating infection from vaccination in foot-and-mouth disease. Veterinary J 2004, 167:9-22.
6. Mackay D.K., Forsyth M.A., Davies P.R., Salt J.S. Antibody to the non-structural proteins of foot-and-mouth disease virus in vaccinated animals exposed to infection. Veterinary Q 1998, 20(Suppl.):S9-S11.
7. Mackay D.K., Forsyth M.A., Davies P.R., Berlinzani A., Belsham G.J., Flint M., Ryan M.D. Differentiating infection from vaccination in foot and mouth disease using a panel of recombinant non structural proteins in ELISA. Vaccine 1998, 16:446-459.
8. Parida S., Anderson J., Cox S.J., Barnett P.V., Paton D.J. Secretary IgA as an indicator of oro-pharyngeal foot-and-mouth disease virus replication and as a tool for post vaccination surveillance. Vaccine 2006, 24:1107-1116.
9. Biswal J.K., Paton D.J., Taylor G., Parida S. Detection of persistently foot-and-mouth disease infected cattle by salivary IgA test. The Global Control of FMD-Tools, Ideas and Ideals 2008, 377-382.
10. Parida S., Oh Y., Reid R.M., Cox S.J., Statham R.J., Mahapatra M., Anderson J., Barnett P.V., Charleston B., Paton D.J. Interferon-γ production in vitro from whole blood of foot-and-mouth disease (FMDV) vaccinated and infected cattle after incubation with inactivated FMDV. Vaccine 2006, 24:964-969.
11. Sorensen K.J., Madsen K.G., Madsen E.S., Salt J.S., Nqindi J., MaKay D.K. Differentiation of infection from vaccination in foot-and-mouth disease by the detection of antibodies to the non-structural proteins 3D, 3AB and 3ABC in ELISA using antigens expressed in baculovirus. Arch Virol 1998, 143:1461-1476.
12. Sorensen K.J., de Stricker K., Dyrting K.C., Grazioli S., Hass B. Differentiation of foot-and-mouth disease virus infected animals from vaccinated animals using blocking ELISA based on baculovirus expressed FMDV 3ABC antigen and a 3ABC monoclonal antibody. Arch Virol 2005, 150:805-814.
13. Brocchi E., Bergmann I.E., Dekker A., Paton D.J., Sammin D.J., Greiner M., Grazioli S., De Simone F., Yadin H., Haas B., Bulut N., Malirat V., Neitzert E., Goris N., Parida S., Sørensen K., De Clercq K. Comparative evaluation of six ELISA's for the detection of antibodies to the non-structural proteins of foot-and-mouth disease virus. Vaccine 2006, 24:6966-6979.
14. Uttenthal A., Parida S., Rasmussen T.B., Paton D.J., Haas B., Dundon W.G. Strategies for differentiating infection in vaccinated animals (DIVA) for foot-and-mouth disease, classical swine fever and avian influenza. Exp Rev Vaccines 2010, 9(1):73-87.
15. Fowler V.L., Paton D.J., Reider E., Barnett PV Chimeric foot-and-mouth disease viruses: evaluation of their efficacy as potential marker vaccines in cattle. Vaccine 2008, 26:1982-1989.
16. Fowler V.L., Knowles N.J., Paton D.J., Barnett P.V. Marker vaccine potential of a foot-and-mouth disease virus with a partial VP1 G-H loop deletion. Vaccine 2010, 28:3428-3434.
17. Ferris N.P., Powell H., Donaldson A.I. Use of precoated immunoplates and freeze-dried reagents for the diagnosis of foot-and-mouth disease and swine vesicular disease by enzyme-linked immunosorbent assay (ELISA). J Virol Methods 1988, 19:197-206.
18. Rweyemamu M. Antigenic variation in foot-and-mouth disease: studies based on the virus neutralisation reaction. J Biol Stand 1984, 12:323-337.
19. Snowdon W.A. Growth of foot-and-mouth disease virus in monolayer cultures of calf thyroid cells. Nature 1966, 210:1079-1080.
20. Reid S., Ferris N.P., Hutchings G.H., Zhang Z., Belsham G.J., Alexandersen S. Detection of all seven serotypes of foot-and-mouth disease virus by real-time, fluorogenic reverse transcription polymerase chain reaction assay. J Virol Methods 2002, 105:67-80.
21. Zhang Z., Alexandersen S. Detection of carrier cattle and sheep persistently infected with foot-and-mouth disease virus by a rapid real-time RT-PCR assay. J Virol Methods 2003, 111:95-100.
22. Beutler E., Gelbart T., Kuhl W. Interference of heparin with the polymerase chain reaction. Biotechniques 1990, 9:166.
23. Barnett P.V., Statham R.J., Vosloo W., Haydon D.T. Foot-and-mouth disease vaccine potency testing: determination and statistical validation of a model using a serological approach. Vaccine 2003, 21:3240-3248.